Atlas Trials

Ixazomib in Combination With Thalidomide - Dexamethasone in Patients With Relapsed and/or Refractory Multiple Myeloma

Clinical trial NCT02410694 · COMPLETED

Trial details

NCT number
NCT02410694
Sponsor
Arbeitsgemeinschaft medikamentoese Tumortherapie
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Multiple Myeloma
Start date
2015-04-01
Primary completion
2019-03-28
Enrollment
90

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.